Page values for "Insulin Degludec"
From Pharmacopedia
More actions
"Medicines" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| generic | String | Insulin degludec |
| brand | String | Tresiba |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Insulins|Insulin]] • [[:Category:Ultra-long-acting_insulins|Ultra-long-acting insulin analog]] • [[:Category:Basal_insulins|Basal insulin]] |
| mechanism | String | '"`UNIQ--vote-00001356-QINU`"' Binds the same insulin receptor as endogenous insulin with comparable mitogenic-to-metabolic ratio'"`UNIQ--ref-00001357-QINU`"'. |
| uses | String | '"`UNIQ--vote-00001358-QINU`"', '"`UNIQ--vote-00001359-QINU`"' |
| starting_dose | String | ~10 units SC at the same time daily, or 0.1-0.2 units/kg/d; titrate by fasting glucose |
| preparations | String | 100 U/mL (FlexTouch pen) and 200 U/mL (FlexTouch pen, higher-dose convenience) |
| fda_max | String | Titrated to glucose; no fixed ceiling |
| pill_id | Text | |
| routes | List of String, delimiter: , | Subcutaneous (never IV; not for use in insulin pumps) |
| onset | String | ~1 hour |
| duration | String | >42 hours per dose (effectively flat once at steady state) |
| halflife | String | ~25 hours apparent (functional duration well over 42 hours from multi-hexamer depot)'"`UNIQ--ref-0000135A-QINU`"' |
| bioavailability | String | ~100% from subcutaneous depot |
| pregnancy | String | Insulin is the preferred glucose-lowering therapy in pregnancy; degludec has reassuring observational data.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |